Skip to main content

Articles By Jack Cush, MD

hospital-840135__180.jpg

Poor Outcomes for Dermato/Polymyositis Admitted to ICU

Idiopathic inflammatory myopathies (IIMs) may be complicated with life-threatening conditions requiring intensive care unit (ICU) admission.  The outcomes of such complications may be dire, but there are few series addressing the outcomes of those admitted to the ICU. 

Read Article
hip-fracture.jpg

Consensus Guideline on Drug Therapy After Osteoporotic Fractures

Silverman and a panel from the IOF Fracture Working Group reviewed the data and trials to develop guidelines for the use of osteoporosis medications after incident fractures or to treat delayed fracture healing.

Read Article
rn.predict.png

KOLs Predict: What Will the Next Year Bring?

A new subspecialty may emerge. New drugs will be approved (but it will be difficult for patients to get coverage for them). And an American team will win the World Series. All these and more: here are predictions for 2017 and beyond from rheumatologists across the country and around the world.  

Read Article
TNFinhib.jpg

Low Adherence to Biologics in Psoriasis Patients

Doshi and colleagues have conducted a retrospective claims analysis (2009 through 2012) of psoriasis patients on Medicare to examine the use and adherence to those initiating treatment with either infliximab, etanercept, adalimumab, or ustekinumab.

Read Article
IPF.CT_.jpg

Can Rituximab Change the Course of Interstitial Lung Disease?

Like other extraarticular manifestations, rheumatoid (RA) or connective tissue disease (CTD) related interstitial lung disease (ILD) is difficult to identify early and equally challenging to treat.

Read Article
read.jpg

Anniversary Feature: Top 5 Most-Read Articles from 1st Year

It is important to know where you’ve been, as it will most certainly color where you are going. Hence, in honor of our 1st year anniversary, we have taken note of our most popular articles.

Read Article
Week%20in%20Review.JPG

RheumNow Week in Review – 22 April 2016

Watch Dr. Jack Cush cover ten highlights from this week on RheumNow.com.

Read Article
seating_0.jpg

Why My Patients Sit Where They Sit

Where do your patients sit? Have you noticed they don't usually sit where you expect them to? What's up with that, and is there a psychology behind one's choice of seating? This curious observation may portend the nature of the physician-patient relationship or, at the very least, impact the layout of your next clinic.

Read Article
vaccine.jpg

Vaccine Success is Limited in Rheumatoid Arthritis

Numerous guidelines (ACR, ACIP/CDC, ATS, NICE) all call for timely vaccinations in patients with rheumatoid arthritis (RA) and those receiving immunosuppressives or biologics. 

Read Article
defensinalpha.png

α Defensin Control of Inflammation

Alpha defensins are released following apoptosis, necrosis, or netosis of human neutrophils. They are taken up by other cells and microbes, wherein they permeablize membranes and kill microbes and host cells. Thus, they augment the antimicrobial capacity of macrophages and at the same time inhibit the biosynthesis of proinflammatory cytokines.

Read Article
×